Ocata Therapeutics Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
65
- Latest Deal Type
-
M&A
- Financing Rounds
-
11
- Investments
-
2
Ocata Therapeutics General Information
Description
Provider of cellular therapies and regenerative medicine. The company provides stem cell-based technologies and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies. It also provides regenerative medicine or regenerating human of cells.
Contact Information
Website
www.ocata.comCorporate Office
- 33 Locke Drive
- Marlborough, MA 01752
- United States
Corporate Office
- 33 Locke Drive
- Marlborough, MA 01752
- United States
Ocata Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ocata Therapeutics Comparisons
Industry
Financing
Details
Ocata Therapeutics Competitors (103)
One of Ocata Therapeutics’s 103 competitors is Maze Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Maze Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Humacyte | Formerly VC-backed | Durham, NC | ||||
| Orgenesis | Corporation | Germantown, MD | ||||
| Gradalis | Private Equity-Backed | Carrollton, TX | ||||
| etherna | Formerly VC-backed | Niel, Belgium |
Ocata Therapeutics Signals
Ocata Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ocata Therapeutics Acquisitions (2)
Ocata Therapeutics’s most recent deal was a Merger/Acquisition with Mytogen for . The deal was made on 20-Sep-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mytogen | 20-Sep-2007 | Merger/Acquisition | Other Healthcare Services | ||
| Infigen | 08-Feb-2007 | Merger/Acquisition | Biotechnology |
Ocata Therapeutics FAQs
-
When was Ocata Therapeutics founded?
Ocata Therapeutics was founded in 1994.
-
Where is Ocata Therapeutics headquartered?
Ocata Therapeutics is headquartered in Marlborough, MA.
-
What is the size of Ocata Therapeutics?
Ocata Therapeutics has 65 total employees.
-
What industry is Ocata Therapeutics in?
Ocata Therapeutics’s primary industry is Drug Discovery.
-
Is Ocata Therapeutics a private or public company?
Ocata Therapeutics is a Private company.
-
What is the current valuation of Ocata Therapeutics?
The current valuation of Ocata Therapeutics is .
-
What is Ocata Therapeutics’s current revenue?
The current revenue for Ocata Therapeutics is .
-
How much funding has Ocata Therapeutics raised over time?
Ocata Therapeutics has raised $106M.
-
Who are Ocata Therapeutics’s investors?
Alpha Capital Partners, Anthem Venture Partners, Brio Capital, Bushido Capital Partners, and Cranshire Capital Advisors are 5 of 19 investors who have invested in Ocata Therapeutics.
-
Who are Ocata Therapeutics’s competitors?
Maze Therapeutics, Humacyte, Orgenesis, Gradalis, and etherna are some of the 103 competitors of Ocata Therapeutics.
-
When was Ocata Therapeutics acquired?
Ocata Therapeutics was acquired on 10-Feb-2016.
-
Who acquired Ocata Therapeutics?
Ocata Therapeutics was acquired by Astellas Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process